Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-01-07 @ 12:46 PM
Study NCT ID:
NCT00974350
Status:
COMPLETED
Last Update Posted:
2021-05-27
First Post:
2009-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair
Sponsor:
Durect
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLIN803-006-0006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dmitri Lissin, MD, Sr. Director Clinical Research
Old Organization:
Durect Corporation
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |